News MSD launches first Herceptin biosimilar in UK Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD.
News Its Herceptin biosimilar nearing launch, Celltrion begins wo... South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda.
News Samsung Bioepis files Herceptin biosimilar in EU South Korean firm trying to copy breast cancer blockbuster.
News Mylan and Biocon file Herceptin biosimilar in Europe First Herceptin biosimilar filed in EU, companies say.
ASCO-pp Eye on ASCO Day 1 - There's life in the old drugs yet The American Society of Clinical Oncology meeting, the world's biggest cancer conference, has kicked off in blazing sunshine and amid much anticipation in Chicago.
News 23andMe fined £2.31m over UK users' genetic data breach Genetic testing company 23andMe is facing a hefty fine from the UK's data protection watchdog for failing to protect its customers' data.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
